Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akari Therapeutics PLC

1.13
-0.0143-1.25%
Post-market: 1.130.00000.00%16:15 EDT
Volume:16.88K
Turnover:19.20K
Market Cap:36.38M
PE:-0.68
High:1.15
Open:1.14
Low:1.11
Close:1.15
Loading ...
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 11, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 05, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 05, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 03, 2024

Major Issues Report

Form 8-K - Current report
Oct 25, 2023

Correspondence

Form CORRESP - Correspondence
Oct 20, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 13, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 31, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 01, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 14, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 07, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 04, 2022

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Oct 12, 2022

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
May 16, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals